A randomised study to evaluate the safety and efficacy of prolonged adjuvant capecitabine chemotherapy on survival of gastric cancer patients after D2 gastrectomy

Trial Profile

A randomised study to evaluate the safety and efficacy of prolonged adjuvant capecitabine chemotherapy on survival of gastric cancer patients after D2 gastrectomy

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top